Cimpress Stock (NASDAQ:CMPR), Trade Ideas

Cimpress

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

CELU

CMPR

NRBO

PTON

REVB

VLCN

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday.

The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&amp;P 500 also rose, gaining, 0.87% to 4,887.70.

Dow Jumps 250 Points; Honeywell Issues Weak Forecast

Movers

ALGM

ASST

BFRG

BOOT

BRTX

CACC

CHRW

CMAX

CMND

CTVA

DGII

EGHT

ELAB

ELWS

ETSY

EVAX

EVER

FBLG

FCEL

HSAI

IFBD

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

MINM

NVIV

NYCB

OGEN

PLUG

PSNY

RACE

RKLB

SPWR

SRDX

TCRT

WOLF

YOSH

ZION

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

ai-generated-8210475_1280

Movers & Shakers

Cimpress beat estimated earnings by 72.58%, reporting quarterly earnings of $2.14 per shares versus the analyst consensus estimate of $1.24. The company reported quarterly sales of $921.36 million which beat the analyst consensus estimate of $892.1 million by 3.28% and represents a 9% increase over sales of $845.20 million the same period last year.

Why Cimpress Stock Is Up After Earnings

Cimpress PLC

GENTERA SAB DE CV ORD by Gentera Sab De CV

Gentera SAB de CV

COMPARTAMOS SAB DE CV ADR by Gentera Sab De CV

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Outperform and raises the price target from $100 to $113.

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Buy and raises the price target from $90 to $110.

Truist Securities Maintains Buy on Cimpress, Raises Price Target to $110-Report Released on 1 February 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday.
The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&amp;P 500 also rose, gaining, 0.87% to 4,887.70.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/36883775/320m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying"> $320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer staples shares rose by 1.6% on Thursday.
In trading on Thursday, energy shares fell by 0.2%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Honeywell International Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hon#NASDAQ">HON</a>) reported downbeat revenue for its fourth quarter and issued weak outlook.
Honeywell reported fourth-quarter fiscal 2023 sales of $9.44 billion, up 3% year-over-year on a reported basis and +2% on an organic basis, missing the consensus of $9.70 billion. Adjusted EPS was $2.60 (+3% Y/Y), beating the consensus of $2.59.
For the first quarter, Honeywell sees adjusted EPS of $2.12-$2.22 (consensus $2.24) and sales of $8.9 billion-$9.2 billion (consensus $9.248 billion).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) shares shot up 23% to $92.54 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.
Shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) got a boost, surging 72% to $5.61 after the company announced FDA clearance of the IND for a Phase 1 clinical trial of DA-1726 for the treatment of obesity.
Celularity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celu#NASDAQ">CELU</a>) shares were also up, gaining 28% to $0.4854. Celularity said it sees FY24 net sales of $50 million to $56 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares dropped 61% to $3.40 after the company announced pricing of $6.2 million public offering.
Shares of Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) were down 23% to $4.2711 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.
Volcon, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) was down, falling 23% to $0.1031 after the company announced a 1-for-45 reverse stock split.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday"> AT&amp;T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.5% to $74.69 while gold traded up 0.3% at $2,074.30.
Silver traded up 0.3% to $23.23 on Thursday while copper fell 1.4% to $3.8520.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 0.37%, London&rsquo;s FTSE 100 fell 0.11% while Spain&rsquo;s IBEX 35 Index fell 0.63% The German DAX fell 0.26% French CAC 40 fell 0.89% while Italy&rsquo;s FTSE MIB Index fell 0.18%.
The inflation rate in the Eurozone fell to 2.8% year-over-year in January from 2.9% in the prior month. The HCOB Eurozone manufacturing PMI climbed to 46.6 in January, recording the highest level in ten months.
The S&amp;P Global UK manufacturing PMI fell to 47 in January versus the preliminary reading of 47.3, while German manufacturing PMI rose to 45.5 in January from 43.3 in December. The HCOB France manufacturing PMI climbed to 43.1 in January from 42.1 in the prior month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Thursday, with Japan&rsquo;s Nikkei 225 falling 0.76%, Hong Kong&rsquo;s Hang Seng Index gaining 0.52% and China&rsquo;s Shanghai Composite Index falling 0.64%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.14%.
The Hong Kong Monetary Authority maintained its base rate at 5.75%. Retail sales in Hong Kong rose 4.8% year-over-year in December compared to a revised 12.4% surge in the earlier month. The au Jibun Bank Japan manufacturing PMI edged higher to 48.0 in January from 47.9 in December.
The HSBC India manufacturing PMI fell to 56.5 in January versus a flash reading of 56.9. The Caixin China general manufacturing PMI came in unchanged at 50.8 in January.
&nbsp;
<h3>Economics</h3>
&nbsp;
Nonfarm business sector labor productivity rose by 3.2% in the fourth quarter compared to a revised 4.9% increase in the third quarter.
Unit labor costs rose an annualized 0.5% in the fourth quarter versus a revised 1.1% decline in the prior period.
U.S. initial jobless claims increased to 224,000 in the week ended January 27, versus a revised 215,000 in the prior week and compared to market estimates of 212,000.
The S&amp;P Global US manufacturing PMI rose to 50.7 in January versus a preliminary reading of 50.3.
Construction spending rose by 0.9% month-over-month to an annual rate of $2,096 billion in December.
The ISM manufacturing PMI rose to 49.1 in January, notching the highest level since Oct. 2022, compared to 47.1 in December, and topping market estimates of 47.
Now Read This: <a href="https://www.benzinga.com/news/24/02/36886117/fastly-general-mills-and-2-other-stocks-insiders-are-selling"> Fastly, General Mills And 2 Other Stocks Insiders Are Selling </a>

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrw#NASDAQ">CHRW</a>) fell sharply during Thursday&rsquo;s session after the company reported worse-than-expected fourth-quarter financial results.
C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company&rsquo;s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion.
C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD.</li>
<li>NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity.</li>
<li>FibroBiologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fblg#NASDAQ">FBLG</a>) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ.</li>
<li>Celularity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celu#NASDAQ">CELU</a>) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million.</li>
<li>Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.</li>
<li>TuSimple Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsp#NASDAQ">TSP</a>) rose 28% to $0.2950.</li>
<li>Elevai Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elab#NASDAQ">ELAB</a>) gained 23.5% to $0.84 after gaining 8% on Wednesday.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) climbed 22.8% to $0.5650.</li>
<li>Kiora Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kprx#NASDAQ">KPRX</a>) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million.</li>
<li>Evaxion Biotech A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evax#NASDAQ">EVAX</a>) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS.</li>
<li>Nextracker Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NASDAQ">NXT</a>) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) jumped 18.1% to $3.5791.</li>
<li>BioRestorative Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brtx#NASDAQ">BRTX</a>) gained 16.4% to $1.8850.</li>
<li>Corteva, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctva#NYSE">CTVA</a>) gained 16.2% to $52.84 after the company reported better-than-expected quarterly financial results, issued 2024 guidance and announced a $1 billion repurchase plan.</li>
<li>Nextracker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NYSE">NXT</a>) jumped 16.1% to $52.56 after the company reported better-than-expected quarterly financial results.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) rose 15.9% to $5.10.</li>
<li>FuelCell Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fcel#NASDAQ">FCEL</a>) gained 15.7% to $1.3885.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) climbed 12.2% to $4.9900. Plug Power said it completed first customer fill of liquid green hydrogen at its Georgia plant.</li>
<li>Credit Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cacc#NASDAQ">CACC</a>) jumped 11.9% to $605.43 following upbeat earnings.</li>
<li>Digi International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dgii#NASDAQ">DGII</a>) gained 11.7% to $27.17 following strong results.</li>
<li>Oragenics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogen#NYSE">OGEN</a>) gained 11.1% to $2.5561 after dipping around 34% on Wednesday. Oragenics recently announced termination of at-market offering program.</li>
<li>Allegro MicroSystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algm#NASDAQ">ALGM</a>) climbed 10.9% to $28.77 following upbeat earnings.</li>
<li>Ferrari N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/race#NYSE">RACE</a>) gained 10.4% to $382.17 after the company reported fourth-quarter financial results and issued 2024 guidance.</li>
<li>Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) rose 9.6% to $72.95 after the company announced the appointment of Elliott Investment Management&rsquo;s Marc Steinberg to its board.</li>
<li>Boot Barn Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) gained 8.4% to $77.79 following upbeat earnings.</li>
<li>Sally Beauty Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbh#NYSE">SBH</a>) jumped 7.4% to $13.24 following upbeat earnings.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) gained 7.2% to $13.53.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) shares gained 6.2% to $13.65 after the company posted fourth-quarter results and announced plans to cut 3,500 jobs. Deutsche Bank plans to increase both share repurchases and dividends by at least 50% year-over-year in 2024.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares dipped 61.1% to $3.4268 after the company announced pricing of $6.2 million public offering.</li>
<li>InVivo Therapeutics Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nviv#NASDAQ">NVIV</a>) fell 49% to $0.3267. InVivo Therapeutics Holdings and subsidiary filed for Chapter 11 bankruptcy in Delaware but plan to continue operating under court supervision as a debtor-in-possession.</li>
<li>Hesai Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsai#NASDAQ">HSAI</a>) declined 28.2% to $4.1817. Hesai Group issued a statement on the U.S. Department of Defense &quot;Chinese Military Companies&quot; list.</li>
<li>FibroBiologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fblg#NASDAQ">FBLG</a>) fell 27.4% to $21.12.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) shares dipped 24.3% to $0.1020 after the company announced a 1-for-45 reverse stock split.</li>
<li>Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) fell 22.9% to $4.2850 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) fell 21.4% to $8.10.</li>
<li>ADDvantage Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aey#NASDAQ">AEY</a>) shares declined 21.3% to $1.4320.</li>
<li>Earlyworks Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elws#NASDAQ">ELWS</a>) fell 21.2% to $0.44 after surging more than 55% on Wednesday.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) shares declined 20.6% to $1.0799 after surging over 115% on Wednesday.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) fell 19.3% to $2.0410.</li>
<li>Rocket Lab USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rklb#NASDAQ">RKLB</a>) shares declined 18.7% to $3.9450 after the company announced a proposed offering of $275 million convertible senior notes.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) fell 18.4% to $3.9736 after declining 9% on Wednesday. Bullfrog AI Holdings recently filed shelf offering of 786,938 shares and accompanying warrants at $6.63 per share and accompanying warrant.</li>
<li>Thermon Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thr#NYSE">THR</a>) fell 16.2% to $27.45 following third-quarter results.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) declined 15.9% to $1.8250 after Volvo Cars said it will no longer provide further funding to the company.</li>
<li>Surmodics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srdx#NASDAQ">SRDX</a>) fell 14.9% to $29.97 following first-quarter results.</li>
<li>MaxLinear, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mxl#NYSE">MXL</a>) shares dipped 14.4% to $17.83 after reporting fourth-quarter results.</li>
<li>8x8, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eght#NASDAQ">EGHT</a>) fell 13.5% to $2.9050 following weak sales.</li>
<li>New York Community Bancorp, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NYSE">NYCB</a>) dipped 13.5% to $5.60 after multiple firms downgraded the stock following the company&#39;s fourth-quarter results.</li>
<li>IHS Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>) fell 11.9% to $3.5050.</li>
<li>Western Alliance Bancorporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wal#NYSE">WAL</a>) dipped 10% to $57.58.</li>
<li>Aflac Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/afl#NYSE">AFL</a>) shares declined 9.7% to $76.17 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Markel Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkl#NYSE">MKL</a>) dipped 9.4% to $1,356.53 after the company reported 2023 financial results.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) shares fell 9.2% to $29.56 following the company&#39;s second-quarter earnings.</li>
<li>Valley National Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vly#NASDAQ">VLY</a>) dipped 8% to $8.85.</li>
<li>Zions Bancorporation, National Association (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zion#NASDAQ">ZION</a>) fell 6.6% to $39.12.</li>
<li>ING Groep N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ing#NYSE">ING</a>) shares declined 5.9% to $13.37 following fourth-quarter results.</li>
<li>Sanofi (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sny#NASDAQ">SNY</a>) fell 3.2% to $48.33 after the company posted fourth-quarter results and named Fran&ccedil;ois-Xavier Roger as Chief Financial Officer.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/36889477/bitcoin-falls-following-jobless-claims-data-jupiter-ftx-token-among-top-losers"> Bitcoin Falls Following Jobless Claims Data; Jupiter, FTX Token Among Top Losers</a>

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Cimpress Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) shares are trading higher Thursday after the company reported better-than-expected second-quarter financial results and announced the repurchase of <a href="https://www.benzinga.com/news/24/02/36891417/eaton-posts-strong-results-joins-ferrari-boot-barn-and-other-big-stocks-moving-higher-on-thursday">up to $150 million of company shares</a>.
The Details:
Cimpress beat estimated earnings by 72.58%, reporting <a href="https://www.benzinga.com/pressreleases/24/01/b36876224/cimpress-reports-second-quarter-fiscal-year-2024-financial-results">quarterly earnings</a> of $2.14 per share versus the analyst consensus estimate of $1.24 per share.
The company reported quarterly sales of $921.36 million which beat the analyst consensus estimate of $892.1 million by 3.28% and represents a 9% increase over sales of $845.20 million the same period last year.
Cimpress also announced a share repurchase program of up to $150 million.
&#8220;We remain focused on execution and our team is incentivized to deliver against the guidance we have provided for the remainder of FY2024. We have significantly expanded profitability and free cash flow over the last year while still investing for growth to enhance our long-term prospects, underlying cash flow generation ability and intrinsic value per share. I remain grateful for your support as we strive to enhance the value we deliver to our customers and long-term investors,&#8221; commented Robert Keane, Cimpress CEO.
 Related News:<a href="https://www.benzinga.com/news/24/01/36827785/whats-going-on-with-rivian-automotive-stock"> What&#8217;s Going On With Rivian Automotive Stock</a><a href="https://www.benzinga.com/news/24/01/36827785/whats-going-on-with-rivian-automotive-stock">?</a>
CMPR Price Action: According to<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>, Cimpress shares are up 25% at $94.15 at the time of publication.
Image: Cambridge Finance from Pixabay

U.S. stocks traded higher midway through trading, with the S&amp;P 500 gaining around 0.5% on Thursday.
The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&amp;P 500 also rose, gaining, 0.48% to 4,868.71.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/36883775/320m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying"> $320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer staples shares rose by 1.4% on Thursday.
In trading on Thursday, financial shares fell by 0.9%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The ISM manufacturing PMI rose to 49.1 in January, notching the highest level since Oct. 2022, compared to 47.1 in December, and topping market estimates of 47.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) shares shot up 24% to $93.21 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.
Shares of NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) got a boost, surging 55% to $5.07 after the company announced FDA clearance of the IND for a Phase 1 clinical trial of DA-1726 for the treatment of obesity.
Celularity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celu#NASDAQ">CELU</a>) shares were also up, gaining 28% to $0.4861. Celularity said it sees FY24 net sales of $50 million to $56 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares dropped 61% to $3.4450 after the company announced pricing of $6.2 million public offering.
Shares of Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) were down 22% to $4.3150 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.
Volcon, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) was down, falling 24% to $0.1020 after the company announced a 1-for-45 reverse stock split.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday"> AT&amp;T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 1.1% to $76.70 while gold traded up 0.5% at $2,077.90.
Silver traded up 0.4% to $23.26 on Thursday while copper fell 1.1% to $3.8645.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 0.45%, London&rsquo;s FTSE 100 fell 0.22% while Spain&rsquo;s IBEX 35 Index fell 0.74% The German DAX fell 0.39% French CAC 40 fell 1.06% while Italy&rsquo;s FTSE MIB Index fell 0.27%.
The inflation rate in the Eurozone fell to 2.8% year-over-year in January from 2.9% in the prior month. The HCOB Eurozone manufacturing PMI climbed to 46.6 in January, recording the highest level in ten months.
The S&amp;P Global UK manufacturing PMI fell to 47 in January versus the preliminary reading of 47.3, while German manufacturing PMI rose to 45.5 in January from 43.3 in December. The HCOB France manufacturing PMI climbed to 43.1 in January from 42.1 in the prior month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Thursday, with Japan&rsquo;s Nikkei 225 falling 0.76%, Hong Kong&rsquo;s Hang Seng Index gaining 0.52% and China&rsquo;s Shanghai Composite Index falling 0.64%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.14%.
The Hong Kong Monetary Authority maintained its base rate at 5.75%. Retail sales in Hong Kong rose 4.8% year-over-year in December compared to a revised 12.4% surge in the earlier month. The au Jibun Bank Japan manufacturing PMI edged higher to 48.0 in January from 47.9 in December.
The HSBC India manufacturing PMI fell to 56.5 in January versus a flash reading of 56.9. The Caixin China general manufacturing PMI came in unchanged at 50.8 in January.
&nbsp;
<h3>Economics</h3>
&nbsp;
Nonfarm business sector labor productivity rose by 3.2% in the fourth quarter compared to a revised 4.9% increase in the third quarter.
Unit labor costs rose an annualized 0.5% in the fourth quarter versus a revised 1.1% decline in the prior period.
U.S. initial jobless claims increased to 224,000 in the week ended January 27, versus a revised 215,000 in the prior week and compared to market estimates of 212,000.
The S&amp;P Global US manufacturing PMI rose to 50.7 in January versus a preliminary reading of 50.3.
Construction spending rose by 0.9% month-over-month to an annual rate of $2,096 billion in December.
The ISM manufacturing PMI rose to 49.1 in January, notching the highest level since Oct. 2022, compared to 47.1 in December, and topping market estimates of 47.
Now Read This: <a href="https://www.benzinga.com/news/24/02/36886117/fastly-general-mills-and-2-other-stocks-insiders-are-selling"> Fastly, General Mills And 2 Other Stocks Insiders Are Selling </a>

Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday.
Shares of Eaton Corporation plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etn#NYSE">ETN</a>) rose sharply during Thursday&rsquo;s session after the company reported better-than-expected fourth-quarter <a href="https://www.benzinga.com/quote/ETN/earnings">financial results and issued FY24 guidance</a>.
Eaton posted adjusted earnings of $2.55 per share, beating market estimates of $2.47 per share. The company&rsquo;s quarterly sales came in at $5.97 billion versus expectations of $5.91 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Eaton shares gained 6.2% to $261.48 on Thursday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) shares surged 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.</li>
<li>Nextracker Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NASDAQ">NXT</a>) rose gained 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) gained 18.1% to $3.5791.</li>
<li>Corteva, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctva#NYSE">CTVA</a>) rose 16.2% to $52.84 after the company reported better-than-expected quarterly financial results, issued 2024 guidance and announced a $1 billion repurchase plan.</li>
<li>Nextracker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NYSE">NXT</a>) surged 16.1% to $52.56 after the company reported better-than-expected quarterly financial results.</li>
<li>Olema Pharmaceuticals, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olma#NASDAQ">OLMA</a>) gained 13.3% to $14.78. Olema Pharmaceuticals filed prospectus related to resale of up to 13.2 million shares of common stock held by selling stockholders.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) rose 12.2% to $4.9900. Plug Power said it completed first customer fill of liquid green hydrogen at its Georgia plant.</li>
<li>Credit Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cacc#NASDAQ">CACC</a>) gained 11.9% to $605.43 following upbeat earnings.</li>
<li>Digi International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dgii#NASDAQ">DGII</a>) rose 11.7% to $27.17 following strong results.</li>
<li>EZCORP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>) rose 11.6% to $9.61 after the company reported better-than-expected quarterly financial results.</li>
<li>Allegro MicroSystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algm#NASDAQ">ALGM</a>) surged 10.9% to $28.77 following upbeat earnings.</li>
<li>Ferrari N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/race#NYSE">RACE</a>) rose 10.4% to $382.17 after the company reported fourth-quarter financial results and issued 2024 guidance.</li>
<li>Lancaster Colony Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lanc#NASDAQ">LANC</a>) surged 10% to $202.15 following strong earnings.</li>
<li>Absci Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/absi#NASDAQ">ABSI</a>) gained 9.8% to $4.35.</li>
<li>Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) climbed 9.6% to $72.95 after the company announced the appointment of Elliott Investment Management&rsquo;s Marc Steinberg to its board.</li>
<li>Boot Barn Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) rose 8.4% to $77.79 following upbeat earnings.</li>
<li>KB Financial Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kb#NYSE">KB</a>) gained 8.3% to $45.77.</li>
<li>Arvinas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arvn#NASDAQ">ARVN</a>) rose 8.3% to $44.94. Goldman Sachs analyst Paul Choi initiated coverage on Arvinas with a Buy rating and announced a price target of $70.</li>
<li>Sally Beauty Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbh#NYSE">SBH</a>) climbed 7.4% to $13.24 following upbeat earnings.</li>
<li>Norfolk Southern Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nsc#NYSE">NSC</a>) gained 7.4% to $251.33. The Wall Street Journal reported that Ancora-led investor group has a $1 billion stake in Norfolk Southern, citing sources.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) climbed 7.2% to $13.53.</li>
<li>Tenet Healthcare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thc#NYSE">THC</a>) rose 6.2% to $87.76.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) shares rose 6.2% to $13.65 after the company posted fourth-quarter results and announced plans to cut 3,500 jobs. Deutsche Bank plans to increase both share repurchases and dividends by at least 50% year-over-year in 2024.</li>
<li>Ball Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ball#NYSE">BALL</a>) jumped 6% to $58.78 following strong earnings.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) climbed 5.8% to $29.30. Li Auto delivered 31,165 vehicles in January 2024, up 105.8% year over year.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday"> AT&amp;T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday</a>

ABSI

ARVN

BALL

EZPW

LANC

OLMA

Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday

WIIM

Cimpress shares are trading higher after the company reported better-than-expected Q2 financial results and said the board authorized the repurchase of up to $150 million of company shares.

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported its Q2 earnings results on Wednesday, January 31, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Cimpress beat estimated earnings by 72.58%, reporting an EPS of $2.14 versus an estimate of $1.24.
Revenue was up $76.16 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.51 which was followed by a 1.08% increase in the share price the next day.
Here's a look at Cimpress's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.34</td>
<td>0.24</td>
<td>-1.17</td>
<td>1.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.17</td>
<td>1.05</td>
<td>-1.88</td>
<td>-5.34</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>770.25M</td>
<td>793.45M</td>
<td>710.30M</td>
<td>901.00M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>757.29M</td>
<td>788.85M</td>
<td>742.16M</td>
<td>845.20M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Cimpress <a href="https://www.benzinga.com/quote/CMPR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Cimpress Q2 Earnings

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported quarterly earnings of $2.14 per share which beat the analyst consensus estimate of $1.24 by 72.58 percent. This is a 140.07 percent increase over losses of $(5.34) per share from the same period last year. The company reported quarterly sales of $921.36 million which beat the analyst consensus estimate of $892.10 million by 3.28 percent. This is a 9.01 percent increase over sales of $845.20 million the same period last year.

Cimpress Q2 EPS $2.14 Beats $1.24 Estimate, Sales $921.36M Beat $892.10M Estimate

Buybacks

Cimpress Board On Dec. 14 Authorized Repurchase Of Up To $150M Aggregate Purchase Price

<h3>Companies Reporting Before The Bell</h3>
&bull; Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
&bull; Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $8.82 billion.
&bull; Regis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGS#NASDAQ">RGS</a>) is likely to report quarterly loss at $1.19 per share on revenue of $52.94 million.
&bull; Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is projected to report quarterly loss at $0.74 per share on revenue of $21.12 billion.
&bull; Hess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HES#NYSE">HES</a>) is likely to report quarterly earnings at $1.47 per share on revenue of $2.60 billion.
&bull; Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) is expected to report quarterly earnings at $3.48 per share on revenue of $1.14 billion.
&bull; Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) is estimated to report quarterly earnings at $0.70 per share on revenue of $1.03 billion.
&bull; Evercore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) is expected to report quarterly earnings at $1.66 per share on revenue of $715.79 million.
&bull; Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) is estimated to report quarterly earnings at $1.32 per share on revenue of $5.04 billion.
&bull; Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) is expected to report quarterly earnings at $0.96 per share on revenue of $1.08 billion.
&bull; Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) is likely to report earnings for its first quarter.
&bull; CGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIB#NYSE">GIB</a>) is likely to report quarterly earnings at $1.36 per share on revenue of $2.68 billion.
&bull; Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) is likely to report quarterly earnings at $3.08 per share on revenue of $6.48 billion.
&bull; Avnet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVT#NASDAQ">AVT</a>) is likely to report quarterly earnings at $1.40 per share on revenue of $6.17 billion.
&bull; Hess Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HESM#NYSE">HESM</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $357.92 million.
&bull; M/I Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHO#NYSE">MHO</a>) is estimated to report quarterly earnings at $4.94 per share on revenue of $1.19 billion.
&bull; Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) is estimated to report quarterly earnings at $0.94 per share on revenue of $1.56 billion.
&bull; Radcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDCM#NASDAQ">RDCM</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $13.55 million.
&bull; Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) is likely to report quarterly loss at $1.43 per share on revenue of $85.16 million.
&bull; Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $1.50 billion.
&bull; Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) is projected to report quarterly earnings at $2.63 per share on revenue of $2.10 billion.
&bull; Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) is projected to report quarterly earnings at $2.10 per share on revenue of $4.66 billion.
&bull; Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $1.39 billion.
&bull; Columbus McKinnon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCO#NASDAQ">CMCO</a>) is projected to report quarterly earnings at $0.68 per share on revenue of $250.34 million.
&bull; Group 1 Automotive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPI#NYSE">GPI</a>) is estimated to report quarterly earnings at $10.48 per share on revenue of $4.41 billion.
&bull; Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) is expected to report quarterly earnings at $5.64 per share on revenue of $10.73 billion.
&bull; GSK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) is likely to report quarterly earnings at $0.75 per share on revenue of $9.61 billion.
&bull; Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) is projected to report earnings for its third quarter.
&bull; Extreme Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $295.61 million.
&bull; New York Community (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $803.17 million.
&bull; Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) is likely to report quarterly earnings at $2.34 per share on revenue of $36.29 billion.
&bull; Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) is projected to report quarterly earnings at $0.76 per share on revenue of $4.01 billion.
&bull; Roper Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) is expected to report quarterly earnings at $4.34 per share on revenue of $1.58 billion.
&bull; Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) is projected to report quarterly earnings at $2.16 per share on revenue of $2.09 billion.
&bull; MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) is projected to report quarterly earnings at $1.73 per share on revenue of $195.93 million.
&bull; Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) is estimated to report quarterly earnings at $0.86 per share on revenue of $3.57 billion.
&bull; Navient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAVI#NASDAQ">NAVI</a>) is likely to report quarterly earnings at $0.75 per share on revenue of $201.17 million.
&bull; Central Pacific Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPF#NYSE">CPF</a>) is estimated to report quarterly earnings at $0.48 per share on revenue of $50.78 million.
&bull; Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) is estimated to report quarterly earnings at $0.51 per share on revenue of $3.59 billion.
&bull; Banco Santander (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAN#NYSE">SAN</a>) is estimated to report earnings for its fourth quarter.
&bull; United Microelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $1.70 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) is projected to report earnings for its first quarter.
&bull; EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $296.28 million.
&bull; Markel Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKL#NYSE">MKL</a>) is estimated to report quarterly earnings at $21.36 per share on revenue of $3.76 billion.
&bull; John B Sanfilippo &amp; Son (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBSS#NASDAQ">JBSS</a>) is estimated to report earnings for its second quarter.
&bull; Unifi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UFI#NYSE">UFI</a>) is likely to report quarterly loss at $0.85 per share on revenue of $135.57 million.
&bull; Credit Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACC#NASDAQ">CACC</a>) is expected to report quarterly earnings at $5.99 per share on revenue of $460.96 million.
&bull; SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) is projected to report quarterly earnings at $0.92 per share on revenue of $479.93 million.
&bull; Good Times Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTIM#NASDAQ">GTIM</a>) is estimated to report earnings for its first quarter.
&bull; Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) is estimated to report quarterly earnings at $1.94 per share on revenue of $958.13 million.
&bull; Hanover Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) is expected to report quarterly earnings at $2.73 per share on revenue of $1.41 billion.
&bull; Brandywine Realty Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDN#NYSE">BDN</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $135.47 million.
&bull; DLH Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLHC#NASDAQ">DLHC</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $101.00 million.
&bull; AvalonBay Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $701.24 million.
&bull; Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) is likely to report quarterly earnings at $1.77 per share on revenue of $521.22 million.
&bull; C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) is projected to report quarterly earnings at $0.81 per share on revenue of $4.34 billion.
&bull; 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $183.49 million.
&bull; Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $1.23 billion.
&bull; Hawkins (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $221.24 million.
&bull; Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) is projected to report quarterly loss at $0.05 per share on revenue of $106.67 million.
&bull; Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) is likely to report quarterly loss at $0.66 per share on revenue of $206.25 million.
&bull; Kulicke &amp; Soffa Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $172.01 million.
&bull; MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $125.11 million.
&bull; Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) is likely to report quarterly earnings at $0.61 per share on revenue of $6.73 billion.
&bull; Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) is likely to report quarterly earnings at $1.45 per share on revenue of $4.40 billion.
&bull; Century Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCS#NYSE">CCS</a>) is expected to report quarterly earnings at $2.28 per share on revenue of $896.79 million.
&bull; Digi Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGII#NASDAQ">DGII</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $105.61 million.
&bull; Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) is estimated to report quarterly earnings at $2.37 per share on revenue of $9.51 billion.
&bull; BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $645.09 million.
&bull; Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) is projected to report quarterly earnings at $1.66 per share on revenue of $1.00 billion.
&bull; UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) is estimated to report quarterly earnings at $1.05 per share on revenue of $2.67 billion.
&bull; MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) is likely to report quarterly loss at $0.26 per share on revenue of $52.47 million.
&bull; Core Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLB#NYSE">CLB</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $127.92 million.
&bull; Meritage Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) is likely to report quarterly earnings at $5.17 per share on revenue of $1.53 billion.
&bull; Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $3.62 billion.
&bull; MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) is expected to report quarterly earnings at $1.90 per share on revenue of $18.46 billion.
&bull; Landstar System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTR#NASDAQ">LSTR</a>) is expected to report quarterly earnings at $1.62 per share on revenue of $1.24 billion.
&bull; Rayonier (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYN#NYSE">RYN</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $229.75 million.
&bull; MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $292.72 million.
&bull; NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) is estimated to report quarterly earnings at $0.48 per share on revenue of $619.23 million.
&bull; Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $332.20 million.
&bull; Landmark Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LARK#NASDAQ">LARK</a>) is likely to report earnings for its fourth quarter.
&bull; PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) is expected to report quarterly earnings at $0.96 per share on revenue of $538.63 million.
&bull; Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) is expected to report quarterly earnings at $2.16 per share on revenue of $931.35 million.
&bull; Vista Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTO#NYSE">VSTO</a>) is estimated to report quarterly earnings at $0.81 per share on revenue of $687.67 million.
&bull; Tetra Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) is likely to report quarterly earnings at $1.34 per share on revenue of $990.66 million.
&bull; Benchmark Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $707.50 million.
&bull; NewMarket (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEU#NYSE">NEU</a>) is likely to report earnings for its fourth quarter.
&bull; Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) is expected to report quarterly earnings at $1.24 per share on revenue of $892.10 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ALGN

APTV

ARAY

CMCO

CNMD

DLHC

EXTR

FLEX

GTIM

HESM

HWKN

JBSS

KEYS

KLIC

LARK

LSTR

MKTX

NAVI

NDAQ

ODFL

OTIS

QCOM

QRVO

RDCM

SEIC

SIGI

SLAB

SLGN

TEVA

TTEK

VSTO

Earnings Scheduled For January 31, 2024

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-01-31. Here's what investors need to know before the announcement.
Analysts estimate that Cimpress will report an earnings per share (EPS) of $1.24. 
Cimpress bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.51, which was followed by a 1.08% increase in the share price the next day.
Here's a look at Cimpress's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.34</td>
<td>0.24</td>
<td>-1.17</td>
<td>1.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.17</td>
<td>1.05</td>
<td>-1.88</td>
<td>-5.34</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.08%</td>
<td>5.14%</td>
<td>21.11%</td>
<td>-9.14%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1706626870_0_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Cimpress were trading at $79.17 as of January 29. Over the last 52-week period, shares are up 122.63%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CMPR/earnings">To track all earnings releases for Cimpress visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Cimpress's Earnings

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Outperform and raises the price target from $91 to $100.

Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $100

AAON

ACHR

ACVA

ALIT

AMRC

AMWD

ARRY

ASGN

ATKR

ATSG

AZEK

AZUL

BLDP

BLNK

CARR

CDAY

CHPT

CLVT

CNHI

CPRT

CSLR

CWST

DRVN

ELIQ

GTLS

ROAD

SCWO

VLRS

Shares of several companies in the broader industrial sector are trading higher amid overall market strength following softer-than-expected October inflation data, which could put less pressure on the Fed to raise rates further.

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) reported quarterly earnings of $0.17 per share. This is a 117.53 percent increase over losses of $(0.97) per share from the same period last year. The company reported quarterly sales of $757.29 million which missed the analyst consensus estimate of $770.25 million by 1.68 percent. This is a 7.66 percent increase over sales of $703.41 million the same period last year.

Cimpress Q1 EPS $0.17 Vs $(0.97) Last Year, Sales $757.29M Miss $770.25M Estimate

Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-10-25. Here's what investors need to know before the announcement.
Analysts estimate that Cimpress will report an earnings per share (EPS) of $-0.33. 
Cimpress bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.81, which was followed by a 5.14% increase in the share price the next day.
Here's a look at Cimpress's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.24</td>
<td>-1.17</td>
<td>1.33</td>
<td>-0.89</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.05</td>
<td>-1.88</td>
<td>-5.34</td>
<td>-0.97</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.14%</td>
<td>21.11%</td>
<td>-9.14%</td>
<td>-13.23%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1698159730_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Cimpress were trading at $60.15 as of October 23. Over the last 52-week period, shares are up 177.42%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CMPR/earnings">To track all earnings releases for Cimpress visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analysts have provided the following ratings for Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) within the last quarter: 
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
According to 4 analyst offering 12-month price targets in the last 3 months, Cimpress has an average price target of $88.75 with a high of $91.00 and a low of $87.00. 
Below is a summary of how these 4 analysts rated Cimpress over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
<img src="https://www.benzinga.com/files/images/story/2023/1694797249_0.png" alt="price target chart" />
This current average has increased by 20.47% from the previous average price target of $73.67. 
<a href="https://www.benzinga.com/quote/CMPR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cimpress analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h1>What Are Analyst Ratings?</h1>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 4 Analyst Ratings Have To Say About Cimpress

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Buy and raises the price target from $87 to $90.

Truist Securities Maintains Buy on Cimpress, Raises Price Target to $90

Truist Securities analyst Youssef Squali reiterates Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) with a Buy and maintains $87 price target.

Reiteration

Truist Securities Reiterates Buy on Cimpress, Maintains $87 Price Target

AGN, CHRW and KLIC are among after hour movers

Cimpress N.V. Ord (CMPR) said after close Wednesday that it earned $2.14 per share in quarter two 2024. On the revenue line, the company reported $921.4 million, beating estimates by $29.3 million.In the same quarter a year ago, the company lost $5.34 per share on revenue of $845.2 million. The stock is up 24.57% to $93.71

Cimpress N.V. Ord Up 24.57% To $93.71 After Earnings Beat

TCRT, NXT and MINM among mid-day movers

Cimpress plc (CMPR) Q2 2024 Earnings Call Transcript

These Communication Services stocks are trading higher:-Cimpress PLC (CMPR) stock is trading at $91.00, an increase of $15.78, or 20.69%, on high volume.  Cimpress N.V. Ord gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $95.0

Communication Services Stocks Moving Up and Down Thursday: CMPR, GMGI, EVER, NETTF, CSSEP, IHS, DRCT, LEE

Cimpress PLC (CMPR) is around the top of the Advertising Agencies industry according to InvestorsObserver. CMPR received an overall rating of 84, which means that it scores higher than 84 percent of all stocks. Cimpress PLC also achieved a score of 100 in the Advertising Agencies industry, putting it above 100 percent of A

Should You Buy Cimpress PLC (CMPR) in Advertising Agencies Industry?

Cimpress PLC (CMPR) is around the top of the Communication Services sector according to InvestorsObserver.CMPR received an overall rating of 82, which means that it scores higher than 82% of stocks. Additionally, Cimpress PLC scored a 99 in the Communication Services sector, ranking it higher than 99% of stocks in that sec

Will Cimpress PLC (CMPR) Beat the Rest of the Stocks in the Communication Services Sector?

AMC, BILI among major communication services gainers; SJ, CMPR among losers

The advertisement industry is burgeoning on the wings of technological progress, precise audience segmentation, and amplified investments across digital and traditional media. In this evolving landscape, Wall Street's distinguished ad stocks comScore (SCOR), Criteo S.A. (CRTO), and Cimpress (CMPR) could be ideal additions to your portfolio at present. Read on… The expansion of the advertisement industry stems from technological advancements, refined audience targeting, and augmented investments in both digital and traditional media platforms. Considering this, esteemed Wall Street ad stocks comScore, Inc. (<a href="https://stocknews.com/stock/SCOR/">SCOR</a>), Criteo S.A. (<a href="https://stocknews.com/stock/CRTO/">CRTO</a>), and Cimpress plc (<a href="https://stocknews.com/stock/CMPR/">CMPR</a>) could make additions to one's portfolio.
Before delving into the featured stocks, let's examine the dynamics of the advertising sector.
The proliferation of smartphones as essential tools for communication, entertainment, and information consumption has prompted advertisers to seize the opportunity to reach a broad and varied audience. The extensive mobile user base offers a fertile environment for dynamic targeted advertising, facilitating real-time engagement between businesses and consumers.
Globally, the widespread embrace of mobile technology has elevated mobile advertising to a pivotal platform for audience outreach and interaction. Fact.MR's recent research reveals that the global mobile advertising market will reach $184.01 billion in 2024, with <a href="https://www.globenewswire.com/news-release/2024/02/07/2825528/0/en/Mobile-Advertising-Market-Set-to-Rise-at-a-9-4-CAGR-Totalling-US-450-018-6-Million-by-2034-Fact-MR-Report.html">a projected 9.4% CAGR</a>, foreseeing a valuation of $450.02 billion by 2034.
Furthermore, <a href="https://www.forbes.com/sites/forbescommunicationscouncil/2024/01/04/15-key-marketing-trends-to-watch-for-in-2024/?sh=72b3682b3b4f">harnessing micro-influencers</a> in advertising could prove advantageous for the industry. These influencers, targeting specific audiences, foster genuine engagement, boosting brand credibility and outreach. Cost-efficient partnerships result in substantial ROI, nurturing authentic connections between brands and consumers, thus driving sectoral expansion.
Moreover, substantial media prospects are anticipated for advertisers stemming from <a href="https://www.dentsu.com/news-releases/dentsu-forecasts-2024-global-ad-spend-to-grow">major cyclical sporting and political events</a> such as UEFA EURO2024 and the United States presidential election. This will propel heightened investments both domestically and internationally, presenting lucrative opportunities for marketers to capitalize on.
Digital advertising is poised to remain the primary catalyst for global ad spend growth, attracting the majority of incremental investments, amounting to an additional $27.1 billion this year. It is projected to maintain an upward trend, reaching $442.6 billion by 2024, comprising 58.8% of total global advertising expenditure.
Additionally, TV is anticipated to rebound with a growth rate of 2.9%, securing a 23.0% share of ad spend by 2024. Meanwhile, print advertising expenditure is forecasted to hit <a href="https://www.statista.com/outlook/amo/advertising/print-advertising/united-states">$10.36 billion this year</a>, with magazine advertising leading as the largest segment at $5.34 billion.
Furthermore, the integration of AI and advanced technology in advertising is driving expansion by enhancing campaign optimization, audience targeting, and content personalization. Advertisers can harness data-driven insights and automation to achieve unprecedented efficiency and effectiveness.
According to the latest dentsu Global Ad Spend Forecasts, advertising expenditure is set to increase by $33.0 billion in 2024, reaching a total of $752.8 billion. This marks a notable 4.6% year-over-year growth for the advertising industry, surpassing the pace observed in 2023.
In light of these encouraging trends, let's look at the fundamentals of the three best <a href="https://stocknews.com/category/advertising/">Advertising</a> stocks, beginning with number 3.
Stock #3: comScore, Inc. (<a href="https://stocknews.com/stock/SCOR/">SCOR</a>)
SCOR operates as an information and analytics firm, evaluating audience and consumer behavior and advertising across diverse media platforms. It provides ratings, planning solutions, and products for measuring movie viewership and box office results, utilizing real-time or near-real-time capture of ticket sales data.
On January 23, 2024, SCOR announced a multi-year agreement with Nexstar Media Group, Inc. (<a href="https://stocknews.com/stock/NXST/">NXST</a>) for cross-platform audience measurement. SCOR will serve as a measurement partner for NXST, supplying vital metrics across its local TV, broadcast, network, and digital ventures. This would significantly expand SCOR's prospects.
In terms of forward non-GAAP P/E, SCOR is trading at 4.45x, 70.5% lower than the industry average of 15.09x. Its forward <a href="https://www.investopedia.com/terms/e/enterprisevaluesales.asp">EV/Sales</a> of 0.78x is 59.1% lower than the 1.91x industry average. Moreover, the stock's forward EV/EBITDA of 6.72x is 21.7% lower than the industry average of 8.57x.
For the fiscal 2023 third quarter that ended September 30, 2023, SCOR's income from operations stood at $2.07 million, compared to a loss of $56.44 million in the prior year's period. Moreover, the company's net income came in at $2.62 million, compared to a net loss of $52.38 million in the previous year's quarter.
Additionally, SCOR's adjusted EBITDA grew 14.3% year-over-year to $13.40 million. As of September 30, 2023, the company's cash and cash equivalents amounted to $30.07 million, up from $20.44 million as of December 31, 2022.
Analysts expect SCOR's revenue to increase 4.4% year-over-year to $390.37 million for the fiscal year ending December 2024. Shares of SCOR have gained 11.3% over the past six months to close the last trading session at $17.80.
SCOR's solid outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
SCOR has an A grade for Growth and a B for Value. It is ranked #4 out of 16 stocks within the <a href="https://stocknews.com/category/advertising/">Advertising</a> industry.
In addition to the POWR Ratings I've highlighted, you can see SCOR's Momentum, Stability, Sentiment, and Quality ratings <a href="https://stocknews.com/stock/SCOR/">here</a>.
Stock #2: Criteo S.A. (<a href="https://stocknews.com/stock/CRTO/">CRTO</a>)
Based in Paris, France, CRTO is a technology firm specializing in marketing and monetization services across the open Internet. It also provides real-time advertising technology and trading infrastructure, empowering media owners, agencies, performance advertisers, and third-party AdTech platforms with advanced media buying, selling, and packaging capabilities.
In terms of forward non-GAAP P/E, the stock is trading at 9.84x, 34.8% lower than the industry average of 15.09x. Its forward EV/Sales of 1.46x is 23.2% lower than the 1.91x industry average. Additionally, CRTO's forward EV/EBITDA of 4.96x is 42.1% lower than the industry average of 8.57x.
For the fiscal 2023 fourth quarter that ended September 30, 2023, CRTO's revenue marginally increased year-over-year to $566.30 million. Its gross profit grew 12.2% from the year-ago value to $276.63 million.
In addition, the company's net income and net income allocated to shareholders per share rose 286.6% and 308% from the prior year's period to $62.05 million and $1.02, respectively.
The consensus revenue estimate of $1.07 billion for the fiscal year ending December 2024 indicates a 5% year-over-year growth. Likewise, the consensus EPS estimate of $3.24 for the ongoing year reflects a 1.9% year-over-year increase. Furthermore, the company topped the consensus revenue and EPS estimates in all four trailing quarters.
Over the past month, the stock has gained 32.1% to close the last trading session at $31.88.
CRTO's robust fundamentals are apparent in its POWR Ratings. The stock has an overall rating of A, which equates to a Strong Buy in our proprietary rating system.
CRTO has an A grade for Growth and Value and a B for Sentiment. It is ranked #2 out of 16 stocks within the same industry.
<a href="https://stocknews.com/stock/CRTO/">Click here</a> to access additional CRTO ratings for Momentum, Stability, and Quality.
Stock #1: Cimpress plc (<a href="https://stocknews.com/stock/CMPR/">CMPR</a>)
CMPR, headquartered in Dundalk, Ireland, offers diverse mass customization services for printing and related items. It also produces and promotes custom writing instruments, promotional products, apparel, and gifts worldwide. The company operates through five segments, Vista; PrintBrothers; The Print Group; National Pen; and All Other Businesses.
In terms of forward EV/Sales, CMPR is trading at 1.17x, 36% lower than the industry average of 1.83x. Its forward EV/EBITDA of 8.39x is 29.5% lower than the 11.90x industry average. Furthermore, the stock's forward Price/Sales of 0.73x is 50.1% lower than the industry average of 1.46x.
For the fiscal 2024 second quarter that ended December 31, 2023, CMPR's revenue increased 9% year-over-year to $921.36 million. Its income from operations rose 220.7% from the year-ago value to $107.68 million.
Additionally, net income and net income per share attributable to CMPR stood at $58.11 million and $2.14, respectively, compared to a net loss and loss per share of $140 million and $5.35 in the prior year's period.
Analysts expect CMPR's revenue to increase 7% year-over-year to $3.29 billion for the fiscal year ending June 2024. The company's EPS for the same period is expected to stand at $3.18. CMPR's shares have gained 25.3% over the past month and 142.4% over the past year, closing the last trading session at $89.98.
CMPR's strong prospects are reflected in its POWR Ratings. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
CMPR has an A grade for Quality and a B for Growth, Value, and Sentiment. It has topped the 16-stock Advertising industry.
<a href="https://stocknews.com/stock/CMPR/">Click here</a> to access the additional CMPR ratings (Momentum and Stability).
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
CMPR shares were trading at $90.78 per share on Thursday afternoon, up $0.80 (+0.89%). Year-to-date, CMPR has gained 13.40%, versus a 5.25% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Aanchal Sugandh</h2> <img src='https:/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg' style="float:left; padding:5px;width:125px;">Aanchal's passion for financial markets drives her work as an investment analyst and journalist. She earned her bachelor's degree in finance and is pursuing the CFA program.

She is proficient at assessing the long-term prospects of stocks with her fundamental analysis skills. Her goal is to help investors build portfolios with sustainable returns.<a href="https://stocknews.com/authors/?author=aanchal-sugandh">More...</a>The post <a href=https://stocknews.com/news/cmpr-crto-scor-nxst-wall-streets-darling-advertising-stock-buys/>Wall Street's Darling Advertising Stock Buys</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Wall Street's Darling Advertising Stock Buys

Cimpress PLC (CMPR) is the highest overall rated company in the Advertising Agencies industry with an overall score of 87. CMPR is up 170.14% so far this year after the company closed yesterday at $93.47.  The overall score measures the company's performance based-off both short and long term indicators and means that CMPR